MedicineWatch US
Class II Recall

Imprimis NJOF, LLC

Product
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Reason
Presence of particulate matter - Glass like particles.
Classification
Class II
Status
Ongoing
Lot
Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Imprimis NJOF, LLC — Class II Recall | MedicineWatch US